mRNA |
BRD-K45681478 |
CTRPv2 |
pan-cancer |
AAC |
0.016 |
0.7 |
mRNA |
cabozantinib |
CTRPv2 |
pan-cancer |
AAC |
0.016 |
0.7 |
mRNA |
MG-132 |
GDSC1000 |
pan-cancer |
AAC |
-0.023 |
0.7 |
mRNA |
KU-60019 |
CTRPv2 |
pan-cancer |
AAC |
0.015 |
0.7 |
mRNA |
Sorafenib |
GDSC1000 |
pan-cancer |
AAC |
-0.025 |
0.7 |
mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.016 |
0.7 |
mRNA |
lenalidomide |
GDSC1000 |
pan-cancer |
AAC |
0.015 |
0.7 |
mRNA |
PRIMA-1-Met |
CTRPv2 |
pan-cancer |
AAC |
0.023 |
0.7 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.013 |
0.7 |
mRNA |
tubastatin A |
GDSC1000 |
pan-cancer |
AAC |
0.013 |
0.7 |